AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Four miRNAs, namely, miR-29a, miR-181a, miR-200b, and miR-218, participated in the pathways: cancer routes, proteoglycans in cancer, PI3K/Akt signaling pathway, chronic myeloid leukemia, adherent junctions, viral carcinogenesis, p53 signaling pathway, fatty acid biosynthesis, and fatty acid metabolism (Figure 4).